We instead hypothesize that impairment in the crosslinking of tau by the <i>TGM6</i>-encoded transglutaminase enzyme may compromise tau functionally and structurally, leading to its aggregation in a pattern currently classified as PSP. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.